Shanghai Serum Bio-Technology Co., Ltd. (SHA:688163)
40.60
-0.53 (-1.29%)
At close: Jul 15, 2026
Shanghai Serum Bio-Technology Employees
Shanghai Serum Bio-Technology had 330 employees as of December 31, 2025. The number of employees increased by 4 or 1.23% compared to the previous year.
Employees
330
Change
4
Growth
1.23%
Revenue / Employee
599.02K CNY
Profits / Employee
147.26K CNY
Market Cap
4.45B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 330 | 4 | 1.23% |
| Jun 30, 2025 | 324 | - | - |
| Dec 31, 2024 | 326 | 5 | 1.56% |
| Dec 31, 2023 | 321 | 13 | 4.22% |
| Dec 31, 2022 | 308 | - | - |
| Dec 31, 2016 | 258 | 51 | 24.64% |
| Jun 30, 2016 | 212 | - | - |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Anhui Huaheng Biotechnology | 2,252 |
| ChemPartner PharmaTech | 1,771 |
| Hefei Lifeon Pharmaceutical | 1,465 |
| Wuhan Hvsen Biotechnology | 1,133 |
| Kexing Biopharm | 1,048 |
| Shanghai Obio Technology (Group) Corp. | 715 |
| Jiangsu Bioperfectus Technologies | 581 |
| Beijing Scitop Bio-tech | 413 |